Spots Global Cancer Trial Database for Samsung Medical Center-Lymphoma Cohort Study

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Samsung Medical Center-Lymphoma Cohort Study

Official Title: Development of a Predictive Model for Treatment Outcome and Treatment-related Morbidity in a Prospective Cohort Study of Patients With Lymphoma

Study ID: NCT00822731

Conditions

Lymphoma

Interventions

Chemotherapy with or without radiotherapy

Study Description

Brief Summary: The purpose of this study is to establish a model which can predict the treatment outcome and the risk of treatment-related morbidity in patients with lymphoma.

Detailed Description: Although the cure rate of lymphoma has been increased due to the development of newer effective drugs, a substantial portion of patients is still suffered from relapse. Furthermore, the treatment-related morbidity is another factor which can make the treatment outcome worse in patients with lymphoma, especially elderly patients. Thus, this study is going to assess following factors which amy probably affect the treatment outcome and the risk of treatment-related morbidity. 1. Biologic factors associated with the aggressiveness of lymphoma * molecular markers in serum, cytogenetic markers 2. Factors associated with the risk of treatment-related morbidity * comorbidity, nutrition status, performance status, quality of life at diagnosis